Approval · Notice of Compliance 20804 · 2018
PEMETREXED: Notice of Compliance 20804
Issued April 27, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20804
- Date
- April 27, 2018
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Revisions to the labels
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PEMETREXED | Not yet assigned | — |
Medicinal ingredients
- PEMETREXED DISODIUM 100 MG per VIAL
- PEMETREXED DISODIUM 500 MG per VIAL